These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 29742509)
1. Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer. Qi L; Ding Y Cell Physiol Biochem; 2018; 46(6):2543-2550. PubMed ID: 29742509 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of HOTAIR expression in colon cancer. Luo ZF; Zhao D; Li XQ; Cui YX; Ma N; Lu CX; Liu MY; Zhou Y World J Gastroenterol; 2016 Jun; 22(22):5254-9. PubMed ID: 27298568 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer. Sporn JC; Jung B Am J Pathol; 2012 Jun; 180(6):2516-26. PubMed ID: 22542848 [TBL] [Abstract][Full Text] [Related]
4. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Narayanan BA; Narayanan NK; Simi B; Reddy BS Cancer Res; 2003 Mar; 63(5):972-9. PubMed ID: 12615711 [TBL] [Abstract][Full Text] [Related]
5. Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Ahmed FE; Vos P; iJames S; Lysle DT; Allison RR; Flake G; Sinar DR; Naziri W; Marcuard SP; Pennington R Cancer Genomics Proteomics; 2007; 4(1):1-20. PubMed ID: 17726236 [TBL] [Abstract][Full Text] [Related]
6. Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma. Hu J; Xu Y; Cai S Eur J Med Res; 2015 Dec; 20():95. PubMed ID: 26626874 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the phosphoenolpyruvate carboxykinase gene in human colon tumors and induction by omega-3 fatty acids. Blouin JM; Bortoli S; Nacfer M; Collinet M; Penot G; Laurent-Puig P; Forest C Biochimie; 2010 Dec; 92(12):1772-7. PubMed ID: 20691246 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance and prognostic value of Nek2 protein expression in colon cancer. Lu L; Zhai X; Yuan R Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer. He L; Deng HY; C Wang X Neoplasma; 2017; 64(1):65-73. PubMed ID: 27881006 [TBL] [Abstract][Full Text] [Related]
11. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination. Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728 [TBL] [Abstract][Full Text] [Related]
12. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870 [TBL] [Abstract][Full Text] [Related]
13. Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma. Shang J; Wang F; Chen P; Wang X; Ding F; Liu S; Zhao Q Dig Dis Sci; 2018 May; 63(5):1219-1228. PubMed ID: 29497907 [TBL] [Abstract][Full Text] [Related]
14. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Guan RJ; Ford HL; Fu Y; Li Y; Shaw LM; Pardee AB Cancer Res; 2000 Feb; 60(3):749-55. PubMed ID: 10676663 [TBL] [Abstract][Full Text] [Related]
15. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer. Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in Colon Cancer. Feng X; Zhang Z; Sun P; Song G; Wang L; Sun Z; Yuan N; Wang Q; Lun L Dis Markers; 2020; 2020():6439614. PubMed ID: 33294056 [TBL] [Abstract][Full Text] [Related]
17. Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Sääf AM; Halbleib JM; Chen X; Yuen ST; Leung SY; Nelson WJ; Brown PO Mol Biol Cell; 2007 Nov; 18(11):4245-60. PubMed ID: 17699589 [TBL] [Abstract][Full Text] [Related]
18. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer. Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145 [TBL] [Abstract][Full Text] [Related]
19. Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer. Long MD; Campbell MJ J Steroid Biochem Mol Biol; 2017 Oct; 173():130-138. PubMed ID: 28027912 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of high-risk stage I and II colon tumors based on evaluation of CAV1 gene expression. Kitowska A; Wesserling M; Seroczynska B; Szutowicz A; Ronowska A; Peksa R; Pawelczyk T J Surg Oncol; 2015 Sep; 112(4):408-14. PubMed ID: 26251082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]